Helicobacter hepaticus induces an inflammatory response in primary human hepatocytes

PLoS One. 2014 Jun 16;9(6):e99713. doi: 10.1371/journal.pone.0099713. eCollection 2014.

Abstract

Helicobacter hepaticus can lead to chronic hepatitis and hepatocellular carcinoma in certain strains of mice. Until now the pathogenic role of Helicobacter species on human liver tissue is still not clarified though Helicobacter species identification in human liver cancer was successful in case controlled studies. Therefore we established an in vitro model to investigate the interaction of primary human hepatocytes (PHH) with Helicobacter hepaticus. Successful co-culturing of PHH with Helicobacter hepaticus was confirmed by visualization of motile bacteria by two-photon-microscopy. Isolated human monocytes were stimulated with PHH conditioned media. Changes in mRNA expression of acute phase cytokines and proteins in PHH and stimulated monocytes were determined by Real-time PCR. Furthermore, cytokines and proteins were analyzed in PHH culture supernatants by ELISA. Co-cultivation with Helicobacter hepaticus induced mRNA expression of Interleukin-1 beta (IL-1β), Tumor necrosis factor-alpha, Interleukin-8 (IL-8) and Monocyte chemotactic protein-1 (MCP-1) in PHH (p<0.05) resulting in a corresponding increase of IL-8 and MCP-1 concentrations in PHH supernatants (p<0.05). IL-8 and IL-1β mRNA expression was induced in monocytes stimulated with Helicobacter hepaticus infected PHH conditioned media (p<0.05). An increase of Cyclooxygenase-2 mRNA expression was observed, with a concomitant increase of prostaglandin E2 concentration in PHH supernatants at 24 and 48 h (p<0.05). In contrast, at day 7 of co-culture, no persistent elevation of cytokine mRNA could be detected. High expression of intercellular adhesion molecule-1 on PHH cell membranes after co-culture was shown by two-photon-microscopy and confirmed by flow-cytometry. Finally, expression of Cytochrome P450 3A4 and albumin mRNA were downregulated, indicating an impairment of hepatocyte synthesis function by Helicobacter hepaticus presence. This is the first in vitro model demonstrating a pathogenic effect of a Helicobacter spp. on human liver cells, resulting in an inflammatory response with increased synthesis of inflammatory mediators and consecutive monocyte activation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aspartate Aminotransferases / metabolism
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism
  • Cells, Cultured
  • Coculture Techniques
  • Culture Media, Conditioned / pharmacology
  • Cyclooxygenase 2 / biosynthesis
  • Cytokines / metabolism
  • Dinoprostone / biosynthesis
  • Enzyme Induction / drug effects
  • Gene Expression Regulation / drug effects
  • Helicobacter hepaticus / drug effects
  • Helicobacter hepaticus / physiology*
  • Hepatocytes / drug effects
  • Hepatocytes / enzymology
  • Hepatocytes / microbiology*
  • Hepatocytes / pathology*
  • Humans
  • Inflammation / pathology*
  • Intercellular Adhesion Molecule-1 / genetics
  • Intercellular Adhesion Molecule-1 / metabolism
  • Microscopy, Fluorescence, Multiphoton
  • Models, Biological
  • Monocytes / drug effects
  • Monocytes / metabolism
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism

Substances

  • Culture Media, Conditioned
  • Cytokines
  • RNA, Messenger
  • Intercellular Adhesion Molecule-1
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Aspartate Aminotransferases
  • Dinoprostone

Grants and funding

Supported by Bayer Health Care, Germany (to M. Kleine and H. Bektas), the “Verein zur Förderung der Forschung und Lehre in der Allgemein Chirurgie” (to M. Kleine), Germany, and grants DFG SFB 621/B8 (to S. Suerbaum), SFB 900/B6 (to C. Josenhans) and DFG SFB 900-B1 (to R. Förster) from the German Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.